Scientific Advisory Boards are the main instrument used by the Max Planck Society for the regular evaluation of its research facilities. The Scientific Advisory Board is composed of internationally recognized scientists, and it functions as an external advisory committee regarding the scientific performance and administrative development of the Institute. The Scientific Advisory Board evaluates the work of the Institute every three years.
KTH Royal Institute of Technology (Sweden)
© Manu Theobald
Ludwig-Maximilians-Universität München (Germany)
EPLF (Switzerland)
Institut Curie (France)
© Gretchen Ertl
University of Chicago (USA)
Stanford University (USA)
Weill Cornel Medicine (USA)
© Steve Fisch Photography
Stanford University (USA)
© Stanford University
Stanford University (USA)
Wellcome/Cancer Research UK Gurdon Institute (UK)
© University of Geneva
University of Geneva (Switzerland)
EMBL Barcelona (Spain)
© Gretchen Ertl/Whitehead Institute
Whitehead Institute at MIT | Howard Hughes Medical Institute (USA)
Cincinnati Children’s Hospital Medical Center (USA)
The Board of Trustees supports the Institute and fosters links between the public and the MPI-CBG. The members of the Board of Trustees are representatives from local politics, industry, science, and the media, and they are appointed by the President of the Max Planck Society. The board meets once a year at the institute, and the Managing Director reports about news, outreach activities, and the latest developments in general.
© David Pinzer
© Martin Förster
Sächsisches Staatsministerium für Wissenschaft, Kultur und Tourismus
© Sparkasse
© IMP
© Leibniz Gesellschaft
© EKFS
© BLEND3 Frank Graetz
© Helmholtz Gesellschaft, David Ausserhofer